Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

Monday, March 16, 2026 1 min read

Key Takeaway: Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

Full Press Release Details

Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin.